Please login to the form below

Not currently logged in
Email:
Password:

Caligor Rx appoints Michael Dallmann as director of strategic planning

He brings experience from Cubist Pharmaceuticals and Peninsula Pharmaceuticals

New Jersey-based Caligor Rx has named Michal Dallman to the newly-created role of as director of strategic planning.

In this position he will be responsible for developing and driving the drug sourcing company's portfolio, including its comparator programmes.

Michael Dallmann: “Through its comparator programmes, Caligor has established an outstanding global reputation marked by the depth of its regulatory expertise, the strength of its relationships with manufacturers and suppliers and the quality of its values. 

“I am delighted to join Caligor and look forward to helping to shape and execute the company's long-term strategic objectives … it's a privilege to be part of this growing organisation.”

Dallmann - who has over two decades of pharmaceutical experience - moves to Caligor from Cubist Pharmaceuticals, which he joined as director of global clinical trial supply in 2013.

Prior to this he also served as associate director of research and development project planning for Peninsula Pharmaceuticals, a Johnson & Johnson company.

Tammy Bishop, Caligor managing director, said: “Mike is an experienced leader who brings the ideal complement of strategic skills to support our growing business.

“His international product development background and the strong relationships he has established over more than two decades in the life sciences industry will serve us well as we continue to expand our services across Europe and Asia.”


5th January 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics